Startup looks to license drugs from Big Pharma

10/25/2011 | InPharm.com

An enterprise by venture capitalist Christopher Evans will acquire early-stage molecules from drugmakers, develop the drugs, then sell them back to the companies once they show clinical value.

View Full Article in:

InPharm.com

Published in Brief: